Top of this page
Skip navigation, go straight to the content
UCB - Inspired by patients. Driven by science.
Menu
Our Company
About us
Management
Sustainability
Green strategy
Partnering
Suppliers
Funding
Disclosure of payments
Responsible Procurement
Disease Areas
Disease areas
Our Science
Our science
Pipeline
UCB Worldwide
Search
Login
Our Products
Products
Newsroom
Overview
Press Releases
Our media stories
Resources
Contact
Patients
Support tools
Life stories
Investors
Overview
UCB equity story
UCB financials
UCB Governance
UCB shareholders
ESG overview
Download center
IR team
HCP
HCP Overview
dermatology
Clinical Studies
Overview
Current studies
Clinical studies index
General information
Data Transparency Policy
Advantage Hers
Advantage Hers English
Advantage Hers German
Advantage Hers French
Advantage Hers Spanish
Advantage Hers Italian
Advantage Hers Danish
Advantage Hers Dutch
Advantage Hers Polish
Advantage Hers Greek
Advantage Hers Finnish
Advantage Hers Norwegian
Advantage Hers Bulgarian
Advantage Hers Czech
Advantage Hers
Advantage Hers English
Advantage Hers German
Advantage Hers French
Advantage Hers Spanish
Advantage Hers Italian
Advantage Hers Danish
Advantage Hers Dutch
Advantage Hers Polish
Advantage Hers Greek
Advantage Hers Finnish
Advantage Hers Norwegian
Advantage Hers Bulgarian
Advantage Hers Czech
Our Company
About us
Management
Sustainability
Green strategy
Partnering
Suppliers
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Greece
Hong Kong
Hungary
Japan
India
Ireland
Italy
Korea
Luxembourg
Malaysia
Mexico
Netherlands
Norway
Poland
Portugal
Romania
Russia
Singapore
Slovakia
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
UK
USA
Requisition to Pay Process
Our Team
Become our supplier
Funding
USA
Other countries
Disclosure of payments
Disclosure of payments to Healthcare Professionals
Denmark
Belgium
Finland
Sweden
Hungary
Italy
Netherlands
Ukraine
Ireland
Norway
Romania
Responsible Procurement
Disease Areas
Disease areas
Our Science
Our science
Pipeline
Clinical Studies
Overview
Current studies
Clinical studies index
UCB6114
UCB86000
Zilucoplan (RA101495)
EVENITY (Romosozumab)
General information
Data Transparency Policy
Our Products
Products
Newsroom
Overview
Press Releases
Our media stories
Resources
Contact
Healthcare Professionals
HCP Overview
dermatology
Patients
Support tools
Life stories
Investors
Overview
UCB equity story
UCB financials
UCB Governance
UCB shareholders
Share repurchase program
Shareholders meeting 2016
Shareholders meeting 2018
Shareholders meeting 2019
Shareholders meeting 2020
ESG overview
Download center
IR team
Careers
Applying to UCB
Search
Language
×
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
Казахстан – ағылшын тілі
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zeeland – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – Inglês
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Français
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
UCB's Global Corporate Website
Healthcare Professionals
HCP Overview
dermatology
Patients
Support tools
Life stories
Investors
Overview
UCB equity story
UCB financials
UCB Governance
UCB shareholders
Share repurchase program
Shareholders meeting 2016
Shareholders meeting 2018
Shareholders meeting 2019
Shareholders meeting 2020
ESG overview
Download center
IR team
Careers
Applying to UCB
Instagram
Facebook
Twitter
YouTube
LinkedIn
RSS
Scroll down to discover UCB
Mobile Menu
Search
UCB - Inspired by patients. Driven by science.
Overview
Press Releases
Our media stories
Resources
Contact
Newsroom
•
Our media stories
Categories
Please select
Investors
Our company
Our Science
Patients
Year
Please select
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Tags
Please select
CSR
epilepsy
Epilepsy
financial results
innovation
Innovation
osteoporosis
Parkinson's disease
partnership
patients
Patients
PD
R&D
research
UCB
16 Dec 2020
Employee engagement and mobility drives better patient outcomes
Read more
4 Dec 2020
Scientific Collaboration and Innovation in Hematology
Read more
23 Nov 2020
Our commitment to innovative technology in Rare Disease
Read more
19 Nov 2020
UCB unleashes the power of data in new collaboration
Read more
12 Nov 2020
UCB strengthens its gene therapy activities
Read more
29 Oct 2020
Award-winning writer and community advocate, Alisha Bridges, shares her …
Read more
Previous
1
2
...
74
75
76
Next
Instagram
Facebook
Twitter
YouTube
LinkedIn
RSS